Penumbra, Inc. (PEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:09PM EDT. Market open.
| Previous close | 177.09 |
| Open | 177.97 |
| Bid | 174.93 x 800 |
| Ask | 175.32 x 800 |
| Day's range | 174.50 - 179.51 |
| 52-week range | 170.59 - 341.23 |
| Volume | |
| Avg. volume | 339,080 |
| Market cap | 6.806B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 74.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Penumbra, Inc. to Present at the Truist Securities MedTech Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024.
- PR Newswire
Penumbra, Inc. to Present at the William Blair Growth Stock Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair Growth Stock Conference on Thursday, June 6, 2024.
- PR Newswire
Penumbra, Inc. Reports First Quarter 2024 Financial Results
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.